Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Jinhe Biotech Stages a $78.6 Million Shenzhen IPO

publication date: Jul 16, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Jinhe Biotechnology, located in Inner Mongolia, raised 490 million RMB ($78.6 million) in an IPO on the Shenzhen Small and Medium exchange. The company placed 27 million A shares of common stock at a price of 18 RMB each, according to filings. Jinhe makes antibiotics that are administered to livestock as feed additives. In 2011, the company reported operating income of $113 million and net profit of $12 million. More details....

Stock Symbol: (SHE: 002688)

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...